Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.
byBenzinga Newsdesk
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Kroger: Q2 Earnings Insights

By Benzinga Insights
September 9, 10:46 AM
  Kroger (NYSE:KR) reported its Q2 earnings results on Friday, September 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Kroger beat estimated earnings by 16.88%, reporting an EPS of $0.9 versus an estimate of $0.77.

KR

Read More

Bitcoin, Ethereum Trade Lower Dogecoin Rises As Stock Futures Slip Into The Red — Analyst Says Despite Bear Market’s 490-Day Length King Crypto Is ‘Here To Stay’

By Shivdeep Dhaliwal
July 19, 11:31 PM
Major cryptocurrencies were mixed on Wednesday evening as the global cryptocurrency market capitalization rose marginally by 0.05% to $1.21 trillion. What Happened: Bitcoin and Ethereum were seen trading in the red while Dogecoin saw gains of nearly 2% at the time of writing. 

$DOGE